These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19367700)

  • 1. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.
    Ohlmeier S; Vuolanto M; Toljamo T; Vuopala K; Salmenkivi K; Myllärniemi M; Kinnula VL
    J Proteome Res; 2008 Dec; 7(12):5125-32. PubMed ID: 19367700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD.
    Ohlmeier S; Mazur W; Linja-Aho A; Louhelainen N; Rönty M; Toljamo T; Bergmann U; Kinnula VL
    J Proteome Res; 2012 Feb; 11(2):599-608. PubMed ID: 22053820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.
    Ishikawa N; Hattori N; Tanaka S; Horimasu Y; Haruta Y; Yokoyama A; Kohno N; Kinnula VL
    Respiration; 2011; 82(1):10-8. PubMed ID: 21474912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
    Chen H; Wang D; Bai C; Wang X
    J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.
    Casado B; Iadarola P; Luisetti M; Kussmann M
    Expert Rev Proteomics; 2008 Oct; 5(5):693-704. PubMed ID: 18937559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
    Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
    Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
    Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
    Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
    Ohlmeier S; Mazur W; Salmenkivi K; Myllärniemi M; Bergmann U; Kinnula VL
    Proteomics Clin Appl; 2010 Jan; 4(1):97-105. PubMed ID: 21137019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
    Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
    APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in proteomic techniques for biomarker discovery in COPD.
    Casado B; Luisetti M; Iadarola P
    Expert Rev Clin Immunol; 2011 Jan; 7(1):111-23. PubMed ID: 21162654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum surfactant protein-A levels in chronic bronchitis and its relation to smoking.
    Behera D; Balamugesh T; Venkateswarlu D; Gupta A; Majumdar S
    Indian J Chest Dis Allied Sci; 2005; 47(1):13-7. PubMed ID: 15704710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating lung and plasma expression of pneumo-proteins in developing biomarkers in COPD: a case study of surfactant protein D.
    Tkacova R; McWilliams A; Lam S; Sin DD
    Med Sci Monit; 2010 Nov; 16(11):CR540-4. PubMed ID: 20980958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Tsoumakidou M; Bouloukaki I; Thimaki K; Tzanakis N; Siafakas NM
    Exp Lung Res; 2010 Aug; 36(6):373-80. PubMed ID: 20653472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs.
    Korfei M; Schmitt S; Ruppert C; Henneke I; Markart P; Loeh B; Mahavadi P; Wygrecka M; Klepetko W; Fink L; Bonniaud P; Preissner KT; Lochnit G; Schaefer L; Seeger W; Guenther A
    J Proteome Res; 2011 May; 10(5):2185-205. PubMed ID: 21319792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of peptide fragments from lung elastin degradation in chronic obstructive pulmonary disease.
    He J; Turino GM; Lin YY
    Exp Lung Res; 2010 Nov; 36(9):548-57. PubMed ID: 20815658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective and therapeutic effect of pulmonary surfactant on the experimental chronic obstructive pulmonary disease in hamsters].
    Li L; Ruan YM; Meng Y; Chen Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):279-84. PubMed ID: 15266830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 27 and cyclophilin A associate with the pathogenesis of COPD.
    Hu R; Ouyang Q; Dai A; Tan S; Xiao Z; Tang C
    Respirology; 2011 Aug; 16(6):983-93. PubMed ID: 21585617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant protein deficiency in familial interstitial lung disease.
    Amin RS; Wert SE; Baughman RP; Tomashefski JF; Nogee LM; Brody AS; Hull WM; Whitsett JA
    J Pediatr; 2001 Jul; 139(1):85-92. PubMed ID: 11445799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.